Live Breaking News & Updates on Lymphatic disorders
Stay updated with breaking news from Lymphatic disorders. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Normal changes to the haematological and cardiovascular systems during pregnancy are explained, and some associated common pathologies and complications highlighted, in the first of this series on how the body changes during pregnancy
THURSDAY, Dec. 15, 2022 (HealthDay News) -- In clinical practice guidelines issued by the Society for Vascular Surgery, American Venous Forum, and American Vein and Lymphatic Society, and published online Oct. 11 in the Journal of Vascular Surgery: Venous and Lymphatic Disorders, recommendations are presented for the diagnosis and treatment of lower-extremity varicose veins. Peter
An anonymous radiologist reports a shocking observation in 2021. This radiologist has witnessed a 360-fold increase in unexplained adenopathy following covid-19 vaccinations. Adenopathy is the [...]
In the past nine months, over 2.1 million covid-19 vaccine injuries have been reported to the World Health Organization’s (WHO) VigiAccess database. This database was created in 2015 to allow the [...]
/PRNewswire/ -- Koya Medical, a healthcare company focused on developing breakthrough treatments for lymphedema and venous diseases, announced today that it...
Hancock Jaffe Announces One Year Follow-up Data on Eleventh VenoValve Patient albuquerqueexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from albuquerqueexpress.com Daily Mail and Mail on Sunday newspapers.
Hancock Jaffe Laboratories, Inc.: Hancock Jaffe Announces One Year Follow-up Data on Eleventh VenoValve Patient IRVINE, CA / ACCESSWIRE / , 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI)(NASDAQ:HJLIW), a developer of medical devices that restore cardiac and vascular health, announced today that the eleventh and final VenoValve patient in HJLI's first-in-human, clinical study has successfully reached the one-year milestone. Patient 11's chronic venous insufficiency ("CVI") has dramatically improved when compared to pre-surgery levels, with reflux (the backwards flow of blood) improving 70%, disease manifestations, as measured by a venous clinical severity scores ("VCSS") improving 69%, and pain, as measured on a visual analog scale ("VAS"), improving 100%.